FasTarg Enables Rapid Discovery of Clean Surface-Accessible, Tumour- Selective TCE Targets
9:00 am - Wednesday 9th December 2026
- FasTarg is an ML/AI-assisted bioinformatics approach to identify novel TCE targets for solid tumour indications
- iOmx’s integrated discovery and development platform enables the generation ofhighly potent TCE compounds
- Show-casing a TCE program with potent tumour cell killing activity and a favourable safety profile
